Joint U.S.-India Study of Lactobacillus and its Phages in Bacterial Vaginosis
Joint U.S.-India Study of Lactobacillus and its Phages in Bacterial Vaginosis
批准号:
7231218
负责人:
ARTHUR L REINGOLD
金额:
$7.32万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2009-08-31
关键词:
AddressAgeAreaAttentionBacteriaBacterial VaginosisBacteriophage TypingBacteriophagesBehaviorBirthCharacteristicsChildChildhoodClinicCohort StudiesCollaborationsCommunitiesConditionCross-Sectional StudiesCytolysisDataDevelopmentEndometritisEnrollmentEpidemiologic StudiesEpidemiologyEtiologyFetal Growth RetardationFollow-Up StudiesFoundationsGenomicsGoalsHerpes Simplex InfectionsHigh PrevalenceHormonal ChangeHuman Herpesvirus 2Hydrogen PeroxideIndiaInfantInfectionInfection of amniotic sac and membranesInterventionJointsLactobacillusLow Birth Weight InfantLyticMaternal MortalityMaternal and Child HealthMediatingMenstrual cycleMorbidity - disease rateMothersNeonatalOutcomeParticipantPlayPopulationPostpartum PeriodPremature LaborPremature Rupture Fetal MembranesPublic HealthRangeRateRelative (related person)ResearchResearch InfrastructureResearch PersonnelRiskRisk FactorsRoleSexually Transmitted DiseasesSpermatocidal AgentsStagingSubgroupTestingTimeTrainingVaginaVaginal DouchingVirusWomancare seekingcohortcostmicroorganismmortalityneonateprospectivereproductivevaginal fluidvaginal lactobacilli
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The proposed study will investigate risk factors for bacterial vaginosis in and characterize Lactobacillus strains and Lactobacillus phages from women of reproductive age in Mysore India. Taking advantage of an existing prospective cohort study of Herpes Simplex 2 infection that has enrolled 750 women of reproductive age, we will enroll 200 women in an exploratory cross-sectional study to investigate the risk factors for bacterial vaginosis among reproductive age women in Mysore, India, and identify and characterize Lactobacillus and Lactobacillus phages among this population. In addition we will carry out a feasibility sub- study following 20 women bimonthly for three months to determine if we can isolate phages directly from women with intermediate vaginal flora, and determine if phage type distribution changes over time in vaginal fluids. This study, the first of its kind ever to be conducted in India, will lay the foundation to test the hypothesis that bacteriophage might be responsible for causing bacterial vaginosis. The aims of the study are to: 1) Collect information about risk factors and correlates of bacterial vaginosis among a population of reproductive-age women in Mysore, India; 2) Identify the Lactobacillus species found in vaginal fluids of a population of reproductive-age women in Mysore, India; 3) Analyze the distribution and types of phages isolated from vaginal Lactobacillus found in vaginal fluids of a population of reproductive-age women in Mysore, India; 4) Investigate the relative change, over time, in phage types found in the vaginal fluids of a small subgroup of women identified as having intermediate vaginal flora. The proposed research addresses the goals of MCHDR in the following ways: 1) It facilitates collaboration on maternal and children's health and contributes to a global understanding of the causes of morbidity and mortality in mothers and children. The research will facilitate the transfer of technical capacity and training to Indian researchers; build infrastructure in a setting where bacterial vaginosis has high public health importance because of its contribution to mortality and morbidity among neonates; focus much needed attention on a condition that has received minimal attention in the past; and provide an opportunity for both Indian and U.S. investigators to better understand the epidemiology, culturally specific risk factors, and role of phages in the etiology of bacterial vaginosis; 2) It addresses a leading cause of maternal, neonatal, and pediatric morbidity and mortality and India and; 3) It focuses on a "high priority" area for MCHDR: investigating "the risk factors for adverse birth outcomes including low birth weight and intrauterine growth retardation".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV Implementation Science Research Training Program
-
批准号:8509546
-
项目类别:
-
资助金额:$27.28万
-
财政年份:2013
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8204681
-
项目类别:
-
资助金额:$16.96万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:7796852
-
项目类别:
-
资助金额:$21.64万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8638660
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:7679337
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8976788
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8775695
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8400387
-
项目类别:
-
资助金额:$19.47万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:9187498
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:7994847
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7036490
-
项目类别:
-
资助金额:$211.84万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7548133
-
项目类别:
-
资助金额:$385.48万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:8205092
-
项目类别:
-
资助金额:$204.24万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7168223
-
项目类别:
-
资助金额:$289.84万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7992826
-
项目类别:
-
资助金额:$298.82万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7345435
-
项目类别:
-
资助金额:$297.88万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program-ARRA-HAI
-
批准号:7895261
-
项目类别:
-
资助金额:$45.84万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:6967230
-
项目类别:
-
资助金额:$285.52万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program-ARRA 317 Supplement
-
批准号:8066520
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program-ARRA-317
-
批准号:7908340
-
项目类别:
-
资助金额:$59.07万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: